|Articles|June 1, 2002

June 2002
Volume 8
Issue 6

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Author(s)Joy L. Meier, PharmD, Arthur L.M. Swislocki, MD, Julio R. Lopez, PharmD

Download PDF: Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Articles in this issue

about 24 years ago

Article

Robbing Tomorrow's Generations

about 24 years ago

Article

Consumer Response to a Report Card Comparing Healthcare Systems

about 24 years ago

Article

Screening for Colorectal Cancer: The Business Case

about 24 years ago

Article

A Nurse-Based Pilot Program to Reduce Cardiovascular Risk Factors in a Primary Care Setting

about 24 years ago

Article

"My Patients Are Sicker:" Using the Pra Risk Survey for Case Finding and Examining Primary Care Site Utilization Patterns in a Medicare-Risk MCO

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

The Timing and Characteristics of Supplemental Indications for Medicines

ByYingying Zhu, PhD,Claire H. Brennan, BA,Haijun Tian, PhD,Josephine N. Tran, PharmD, MS,Peter J. Neumann, ScD,James D. Chambers, PhD,Pei-Jung Lin, PhD,Meng Li, PhD

July 6th 2026

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Articles in this issue

Related Content

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

Trending on AJMC

Ebola Cases Top 1700 as Unpaid Health Workers Strike

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Gene Therapy Could Ease Wet AMD's Injection Burden: Carl Regillo, MD

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Articles in this issue

Related Content

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

The Timing and Characteristics of Supplemental Indications for Medicines

Trending on AJMC

Ebola Cases Top 1700 as Unpaid Health Workers Strike

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

FDA Expands Approval for VWD Prophylaxis in Children Younger Than 6

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Gene Therapy Could Ease Wet AMD's Injection Burden: Carl Regillo, MD